{"id":"https://openalex.org/W2039964553","doi":"https://doi.org/10.1158/1078-0432.ccr-05-0740","title":"In vivo Evaluation of Ixabepilone (BMS247550), A Novel Epothilone B Derivative, against Pediatric Cancer Models","display_name":"In vivo Evaluation of Ixabepilone (BMS247550), A Novel Epothilone B Derivative, against Pediatric Cancer Models","publication_year":2005,"publication_date":"2005-10-01","ids":{"openalex":"https://openalex.org/W2039964553","doi":"https://doi.org/10.1158/1078-0432.ccr-05-0740","mag":"2039964553","pmid":"https://pubmed.ncbi.nlm.nih.gov/16203787"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-05-0740","doi":"https://doi.org/10.1158/1078-0432.ccr-05-0740","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-05-0740","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Jennifer K. Peterson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer K. Peterson","raw_affiliation_strings":["1Molecular Pharmacology and Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Molecular Pharmacology and Departments of","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Chandra Tucker","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chandra Tucker","raw_affiliation_strings":["1Molecular Pharmacology and Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Molecular Pharmacology and Departments of","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5141110200","display_name":"Edward Favours","orcid":"https://orcid.org/0009-0001-2023-2912","observed_orcids":["https://orcid.org/0009-0001-2023-2912"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edward Favours","raw_affiliation_strings":["1Molecular Pharmacology and Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Molecular Pharmacology and Departments of","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111763983","display_name":"Pamela J. Cheshire","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pamela J. Cheshire","raw_affiliation_strings":["1Molecular Pharmacology and Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Molecular Pharmacology and Departments of","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046939499","display_name":"Jeremy Creech","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeremy Creech","raw_affiliation_strings":["1Molecular Pharmacology and Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Molecular Pharmacology and Departments of","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048193615","display_name":"Catherine A. Billups","orcid":"https://orcid.org/0000-0003-2819-4946","observed_orcids":["https://orcid.org/0000-0003-2819-4946"]},"institutions":[{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Catherine A. Billups","raw_affiliation_strings":["2Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee; and","institution_ids":["https://openalex.org/I1313298211"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014115612","display_name":"Richard A. Smykla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard Smykla","raw_affiliation_strings":["3Oncology Drug Discovery, Pharmaceutical Research Institute, Bristol Myers Squibb, Co., Princeton, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Oncology Drug Discovery, Pharmaceutical Research Institute, Bristol Myers Squibb, Co., Princeton, New Jersey","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086704967","display_name":"Francis Y. Lee","orcid":"https://orcid.org/0000-0003-2275-2441","observed_orcids":["https://orcid.org/0000-0003-2275-2441"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Francis Y.F. Lee","raw_affiliation_strings":["3Oncology Drug Discovery, Pharmaceutical Research Institute, Bristol Myers Squibb, Co., Princeton, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Oncology Drug Discovery, Pharmaceutical Research Institute, Bristol Myers Squibb, Co., Princeton, New Jersey","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109173471","display_name":"Peter J. Houghton","orcid":"https://orcid.org/0000-0002-2400-8184","observed_orcids":["https://orcid.org/0000-0002-2400-8184"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter J. Houghton","raw_affiliation_strings":["1Molecular Pharmacology and Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Molecular Pharmacology and Departments of","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.1381,"has_fulltext":false,"cited_by_count":85,"citation_normalized_percentile":{"value":0.94243764,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"11","issue":"19","first_page":"6950","last_page":"6958"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.9106000065803528,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.9106000065803528,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10492","display_name":"Microtubule and mitosis dynamics","score":0.07010000199079514,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ixabepilone","display_name":"ixabepilone","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pediatric-cancer","display_name":"childhood cancer","score":0.6890000104904175},{"id":"https://openalex.org/keywords/microtubule-stabilizing-agents","display_name":"microtubule-stabilizing agents","score":0.8840000033378601},{"id":"https://openalex.org/keywords/antimitotic-agents","display_name":"antimitotic agents","score":0.875},{"id":"https://openalex.org/keywords/rhabdomyosarcoma","display_name":"rhabdomyosarcoma","score":0.9570000171661377},{"id":"https://openalex.org/keywords/neuroblastoma","display_name":"neuroblastoma","score":1.0},{"id":"https://openalex.org/keywords/wilms-tumor","display_name":"Wilms tumor","score":0.9879999756813049},{"id":"https://openalex.org/keywords/osteosarcoma","display_name":"osteosarcoma","score":1.0},{"id":"https://openalex.org/keywords/brain-tumors","display_name":"brain tumors","score":0.9760000109672546},{"id":"https://openalex.org/keywords/paclitaxel-comparison","display_name":"paclitaxel comparison","score":0.7919999957084656},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9620000123977661},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7459999918937683},{"id":"https://openalex.org/keywords/scid-mice","display_name":"SCID mice","score":0.6240000128746033},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.6330000162124634}],"concepts":[{"id":"https://openalex.org/C2779194965","wikidata":"https://www.wikidata.org/wiki/Q11711607","display_name":"Ixabepilone","level":5,"score":0.9253888130187988},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6082243919372559},{"id":"https://openalex.org/C2777526313","wikidata":"https://www.wikidata.org/wiki/Q408201","display_name":"Epothilone","level":2,"score":0.6047304272651672},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4913436472415924},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4683842957019806},{"id":"https://openalex.org/C111771559","wikidata":"https://www.wikidata.org/wiki/Q66295","display_name":"Derivative (finance)","level":2,"score":0.4353216886520386},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.43047839403152466},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37901538610458374},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.29422685503959656},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.21536529064178467},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2119007110595703},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.08402997255325317},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.06008976697921753},{"id":"https://openalex.org/C106159729","wikidata":"https://www.wikidata.org/wiki/Q2294553","display_name":"Financial economics","level":1,"score":0.0},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008870","descriptor_name":"Microtubules","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008938","descriptor_name":"Mitosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008956","descriptor_name":"Models, Chemical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009368","descriptor_name":"Neoplasm Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009396","descriptor_name":"Wilms Tumor","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009447","descriptor_name":"Neuroblastoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012208","descriptor_name":"Rhabdomyosarcoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012516","descriptor_name":"Osteosarcoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014748","descriptor_name":"Vinca Alkaloids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016513","descriptor_name":"Mice, SCID","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D034261","descriptor_name":"Epothilones","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D034261","descriptor_name":"Epothilones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D034261","descriptor_name":"Epothilones","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.ccr-05-0740","doi":"https://doi.org/10.1158/1078-0432.ccr-05-0740","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-05-0740","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:16203787","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16203787","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1292651958","display_name":"MTOR as a Therapeutic Target in Childhood Cancer","funder_award_id":"R01CA096696","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5145123177","display_name":"Studies of Childhood Solid Tumors","funder_award_id":"P01CA023099","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000904664","display_name":"Cancer Center Support Grant (CCSG)","funder_award_id":"P30CA021765","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W1545612850","https://openalex.org/W1612286138","https://openalex.org/W1812462844","https://openalex.org/W1862366084","https://openalex.org/W1917539986","https://openalex.org/W1947572199","https://openalex.org/W1967171039","https://openalex.org/W1972780065","https://openalex.org/W1985858069","https://openalex.org/W2012681221","https://openalex.org/W2035897574","https://openalex.org/W2070434131","https://openalex.org/W2095606573","https://openalex.org/W2106448082","https://openalex.org/W2109589295","https://openalex.org/W2113887833","https://openalex.org/W2125342449","https://openalex.org/W2126358767","https://openalex.org/W2143863165","https://openalex.org/W2146861790","https://openalex.org/W2147051864","https://openalex.org/W2153544919","https://openalex.org/W2158749015","https://openalex.org/W2204696794","https://openalex.org/W2228067035","https://openalex.org/W2325692726","https://openalex.org/W2620176919","https://openalex.org/W2911492642","https://openalex.org/W4243293292"],"related_works":["https://openalex.org/W2228067035","https://openalex.org/W2240137614","https://openalex.org/W177209949","https://openalex.org/W2183800018","https://openalex.org/W2146472326","https://openalex.org/W2005263416","https://openalex.org/W2532643926","https://openalex.org/W2071576714","https://openalex.org/W2123148157","https://openalex.org/W2145042104"],"abstract_inverted_index":{"PURPOSE:":[0],"Vinca":[1],"alkaloids,":[2],"agents":[3,21],"that":[4,22,222,304,352,366],"cause":[5],"depolymerization":[6],"of":[7,14,36,46,56,64,121,156,161,165,171,176,190,218,235,246,251,260,267,290,327,344,376,393],"microtubules,":[8,24],"are":[9,25],"highly":[10,224],"active":[11],"in":[12,60,144,154,275,282,310,315,330,358,368,391],"treatment":[13,227],"many":[15],"pediatric":[16,65,345,394],"cancers.":[17],"In":[18,202],"contrast,":[19],"taxanes,":[20],"stabilize":[23],"far":[26],"less":[27],"effective":[28],"against":[29,341],"the":[30,37,43,124,134,182,207,210,258,285,332,353,371,384],"same":[31,211],"cancer":[32],"types.":[33],"The":[34,263],"purpose":[35],"current":[38],"study":[39],"was":[40,72,185],"to":[41,81,214,226,279,325,365,397],"evaluate":[42],"antitumor":[44],"activity":[45,309,340],"ixabepilone,":[47],"an":[48],"epothilone":[49,333,399],"B":[50,334],"derivative":[51,335,400],"representing":[52],"a":[53,61,118,145,302,342,388],"new":[54],"class":[55],"microtubule-stabilizing":[57],"antimitotic":[58],"agent":[59],"wide":[62],"variety":[63],"solid":[66,395],"tumor":[67,107,168,179,220,346],"models.":[68,180,348],"EXPERIMENTAL":[69],"DESIGN:":[70],"Ixabepilone":[71],"administered":[73,205,379],"i.v.":[74,233],"every":[75,299,380],"4":[76],"days":[77],"for":[78],"three":[79,155,157,160,219],"doses":[80,321],"scid":[82],"mice":[83,276,359],"bearing":[84],"s.c.":[85],"human":[86],"rhabdomyosarcoma":[87,158],"(three":[88],"lines),":[89],"neuroblastoma":[90],"(four),":[91,96],"Wilms'":[92,167],"tumors":[93,99,143,192,396],"(six),":[94],"osteosarcoma":[95],"or":[97,109,149,196,296],"brain":[98,178],"(seven).":[100],"Tumor":[101],"diameters":[102],"were":[103,111,115,223,242],"measured":[104],"weekly,":[105],"and":[106,174,254],"growth":[108],"regressions":[110,217],"determined.":[112],"Pharmacokinetic":[113,349],"studies":[114],"done":[116],"following":[117,231],"single":[119,232],"administration":[120,234],"drug":[122,265],"at":[123,199,206,237,269,320,360,370],"maximum":[125],"tolerated":[126],"dose":[127,273,289,375],"(MTD)":[128],"level":[129,274],"(10":[130,136,240],"mg/kg).":[131],"RESULTS:":[132],"At":[133],"MTD":[135,208,239,272,329,362],"mg/kg),":[137],"ixabepilone":[138,236,268,336,355],"induced":[139],"objective":[140,216],"responses":[141],"(all":[142],"group":[146],"achieved":[147,264,281,357,367],">":[148],"=":[150,197],"50%":[151],"volume":[152],"regression)":[153],"lines,":[159],"five":[162],"neuroblastomas,":[163],"six":[164,172],"seven":[166],"models,":[169],"two":[170],"osteosarcoma,":[173],"four":[175],"eight":[177],"However,":[181],"dose-response":[183],"curve":[184,259],"steep":[186],"with":[187,228,244,402],"only":[188],"2":[189],"19":[191],"models":[193],"regressing":[194],"(>":[195],"50%)":[198],"4.4":[200],"mg/kg.":[201],"comparison,":[203],"paclitaxel":[204],"on":[209],"schedule":[212],"failed":[213],"induce":[215],"lines":[221],"sensitive":[225],"ixabepilone.":[229],"Pharmacokinetics":[230],"its":[238,328,361],"mg/kg)":[241],"biexponential":[243],"C(max)":[245],"12.5":[247],"micromol/L,":[248],"elimination":[249],"half-life":[250],"19.2":[252],"hours,":[253],"total":[255],"area":[256],"under":[257],"5.8":[261],"micromol/L-h.":[262],"exposure":[266,356],"this":[270,398],"efficacious":[271],"is":[277,363],"similar":[278,364],"those":[280],"patients":[283,369],"given":[284],"recommended":[286,372],"phase":[287,311,373],"II":[288,312,374],"40":[291,377],"mg/m2":[292,378],"by":[293],"either":[294],"1-":[295],"3-hour":[297],"infusion":[298],"3":[300,381],"weeks,":[301],"regimen":[303],"has":[305],"shown":[306],"significant":[307],"anticancer":[308],"clinical":[313],"trials":[314],"adult":[316],"patients.":[317],"CONCLUSIONS:":[318],"Administered":[319],"ranging":[322],"from":[323],"66%":[324],"100%":[326],"mice,":[331],"shows":[337],"broad":[338],"spectrum":[339],"panel":[343],"xenograft":[347],"analysis":[350],"indicates":[351],"systemic":[354],"weeks.":[382],"Importantly,":[383],"present":[385],"results":[386],"showed":[387],"clear":[389],"distinction":[390],"sensitivity":[392],"compared":[401],"paclitaxel.":[403]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}